Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Mar-24 5:33 PM View:  | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Mar-24 | Sale | 90,000 | $30.60 | $2,754,000.00 | (80%) 112.13K to 22.13K | |
| 08-Mar-24 5:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Mar-24 | Sale | 28,257 | $30.81 | $870,598.00 | (20%) 140.38K to 112.13K | |
| 08-Mar-24 5:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Mar-24 | Sale | 1,066 | $29.67 | $31,628.20 | (< 1%) 141.45K to 140.38K | |
| 19-Dec-23 6:39 PM View: | TrovaGene, Inc. (CRDF) | 19-Dec-23 | Private Purchase | 30,000 | $1.37 | $41,100.00 | 4% 667.76K to 697.76K | |
| 14-Nov-23 10:00 PM View: | TrovaGene, Inc. (CRDF) | 10-Nov-23 | Private Purchase | 22,950 | $0.98 | $22,491.00 | 4% 644.81K to 667.76K | |
| 15-May-23 6:53 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-May-23 | Option Exercise | 7,000 | $29.90 | $209,300.00 | 5% 137.69K to 144.69K | |
| 15-May-23 6:53 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-May-23 | Option Sale | 5,015 | $41.78 | $209,527.00 | (3%) 144.69K to 139.68K | |
| 19-Sep-22 8:37 AM View: | TrovaGene, Inc. (CRDF) | 15-Sep-22 | Private Purchase | 150,000 | $1.71 | $256,500.00 | 30% 494.81K to 644.81K | |
| 08-Jun-22 7:37 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 1,160 | -- | -- | < 1% 136.53K to 137.69K | |
| 07-Mar-22 8:07 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Mar-22 | Option Exercise | 7,000 | $10.81 | $75,670.00 | 5% 129.53K to 136.53K | |
| 01-Mar-22 6:03 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Mar-22 | Option Exercise | 1,359 | $11.02 | $14,976.20 | 1% 129.53K to 130.89K | |
| 01-Mar-22 6:03 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Mar-22 | Option Sale | 1,359 | $67.75 | $92,072.20 | (1%) 130.89K to 129.53K | |
| 01-Mar-22 6:03 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Feb-22 | Option Exercise | 28,641 | $11.02 | $315,624.00 | 22% 129.53K to 158.17K | |
| 01-Mar-22 6:03 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Feb-22 | Option Sale | 28,641 | $66.83 | $1,914,080.00 | (18%) 158.17K to 129.53K | |
| 22-Sep-21 10:00 PM View: | TrovaGene, Inc. (CRDF) | 21-Sep-21 | Market Purchase | 30,000 | $6.75 | $202,500.00 | 6% 464.81K to 494.81K | 9% |
| 11-Jun-21 8:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 1,066 | -- | -- | < 1% 128.46K to 129.53K | |
| 11-Jun-21 8:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-May-21 | Gift | 1,485 | -- | -- | (1%) 129.95K to 128.46K | |
| 24-Mar-21 10:27 AM View: | TrovaGene, Inc. (CRDF) | 23-Mar-21 | Market Purchase | 10,000 | $10.23 | $102,300.00 | 2% 454.81K to 464.81K | (2%) |
| 19-Mar-21 11:34 AM View: | TrovaGene, Inc. (CRDF) | 18-Mar-21 | Market Purchase | 3,000 | $10.55 | $31,660.00 | < 1% 451.81K to 454.81K | (2%) |
| 04-Mar-21 8:46 PM View: | TrovaGene, Inc. (CRDF) | 04-Mar-21 | Market Purchase | 1,500 | $9.27 | $13,897.50 | < 1% 450.31K to 451.81K | |
| 29-Sep-20 5:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 25-Sep-20 | Option Exercise | 70,000 | $16.67 | $1,166,900.00 | 117% 59.95K to 129.95K | |
| 17-Sep-20 9:42 AM View: | TrovaGene, Inc. (CRDF) | 16-Sep-20 | Market Purchase | 2,550 | $5.70 | $14,526.50 | < 1% 447.76K to 450.31K | |
| 11-Jun-20 6:27 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 1,260 | -- | -- | 2% 58.69K to 59.95K | |
| 13-May-20 4:16 PM View: | TrovaGene, Inc. (CRDF) | 11-May-20 | Market Purchase | 447,761 | $1.34 | $600,000.00 | 100% 0 to 447.76K | |
| 16-Mar-20 5:54 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Mar-20 | Option Exercise | 21,736 | $4.46 | $96,845.00 | 59% 36.95K to 58.69K | |
| 06-Jun-19 4:52 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-19 | Grant | 4,134 | -- | -- | 13% 32.82K to 36.95K | |
| 21-Nov-18 4:07 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 19-Nov-18 | Market Purchase | 4,500 | $46.18 | $207,810.00 | 16% 28.32K to 32.82K | 28% |
| 09-Nov-18 4:30 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Nov-18 | Market Purchase | 4,000 | $51.29 | $205,160.00 | 16% 24.32K to 28.32K | 16% |
| 15-Jun-18 7:17 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-18 | Grant | 782 | -- | -- | 3% 23.54K to 24.32K | |
| 10-May-18 7:07 AM View: | ResMed Inc. (RMD) | 08-May-18 | Option Exercise | 28,403 | $27.58 | $783,355.00 | 28% 100.58K to 128.98K | |
| 10-May-18 7:07 AM View: | ResMed Inc. (RMD) | 08-May-18 | Market Option Sale | 28,403 | $97.37 | $2,765,600.00 | (22%) 128.98K to 100.58K | (168%) |
| 17-Nov-17 9:46 PM View: | ResMed Inc. (RMD) | 16-Nov-17 | Grant | 2,991 | -- | -- | 3% 97.59K to 100.58K | |
| 16-Jun-17 11:20 AM View: | ResMed Inc. (RMD) | 15-Jun-17 | Option Exercise | 22,660 | $33.70 | $763,642.00 | 23% 97.59K to 120.25K | |
| 16-Jun-17 11:20 AM View: | ResMed Inc. (RMD) | 15-Jun-17 | Market Option Sale (Planned) | 22,660 | $76.00 | $1,722,160.00 | (19%) 120.25K to 97.59K | (238%) |
| 16-Jun-17 11:20 AM View: | ResMed Inc. (RMD) | 14-Jun-17 | Option Exercise | 1,730 | $33.70 | $58,301.00 | 2% 97.59K to 99.32K | |
| 16-Jun-17 11:20 AM View: | ResMed Inc. (RMD) | 14-Jun-17 | Market Option Sale (Planned) | 1,730 | $76.00 | $131,480.00 | (2%) 99.32K to 97.59K | (238%) |
| 16-Jun-17 8:17 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Jun-17 | Grant | 1,357 | -- | -- | 6% 22.18K to 23.54K | |
| 17-Nov-16 8:58 PM View: | ResMed Inc. (RMD) | 16-Nov-16 | Grant | 4,429 | -- | -- | 5% 93.16K to 97.59K | |
| 22-Aug-16 6:18 PM View: | ResMed Inc. (RMD) | 19-Aug-16 | Option Exercise | 36,000 | $25.54 | $919,440.00 | 39% 93.16K to 129.16K | |
| 22-Aug-16 6:18 PM View: | ResMed Inc. (RMD) | 19-Aug-16 | Market Option Sale | 36,000 | $69.93 | $2,517,340.00 | (28%) 129.16K to 93.16K | (273%) |
| 17-Jun-16 4:54 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Jun-16 | Grant | 1,488 | -- | -- | 7% 20.69K to 22.18K | |
| 14-Mar-16 12:47 PM View: | ResMed Inc. (RMD) | 11-Mar-16 | Option Exercise | 36,000 | $23.88 | $859,500.00 | 39% 93.16K to 129.16K | |
| 14-Mar-16 12:47 PM View: | ResMed Inc. (RMD) | 11-Mar-16 | Market Option Sale (Planned) | 36,000 | $60.00 | $2,160,000.00 | (28%) 129.16K to 93.16K | (340%) |
| 05-Jun-15 6:30 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-15 | Grant | 2,000 | -- | -- | 11% 18.69K to 20.69K | |
| 17-Mar-15 8:06 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Mar-15 | Market Purchase | 1,000 | $93.83 | $93,829.90 | 6% 17.69K to 18.69K | (37%) |
| 28-Jan-15 8:24 PM View: | ResMed Inc. (RMD) | 26-Jan-15 | Option Exercise | 48,000 | $16.50 | $791,904.00 | 52% 93.16K to 141.16K | |
| 28-Jan-15 8:24 PM View: | ResMed Inc. (RMD) | 26-Jan-15 | Market Option Sale | 48,000 | $66.77 | $3,204,820.00 | (34%) 141.16K to 93.16K | (305%) |
| 21-Nov-14 6:07 PM View: | ResMed Inc. (RMD) | 19-Nov-14 | Grant | 4,885 | -- | -- | 6% 88.27K to 93.16K | |
| 20-Aug-14 8:58 PM View: | ResMed Inc. (RMD) | 18-Aug-14 | Option Exercise | 36,000 | $21.02 | $756,900.00 | 47% 77.27K to 113.27K | |
| 20-Aug-14 8:58 PM View: | ResMed Inc. (RMD) | 18-Aug-14 | Market Option Sale | 25,000 | $51.60 | $1,290,050.00 | (22%) 113.27K to 88.27K | (430%) |